Table 2.
Summary results of effects of COVID-19 on vaccination outcomes.
| Vaccine | Receipt of vaccination (A) |
Receipt of vaccination within 45 days of eligibility (B) |
Receipt of vaccination within 28 days of eligibility (C) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Coefficient∗ | N | N (siblings) | Coefficient∗ | N | N (siblings) | Coefficient∗ | N | N (siblings) | |
| BCG | −1.94∗∗ (0.006) | 132,335 | 59,506 | −0.47 (0.01) | 113,421 | 50,121 | 0.15 (0.011) | 113,421 | 50,121 |
| HepB0 | −2.49∗ (0.01) | 131,240 | 58,972 | −1.69 (0.011) | 115,589 | 51,620 | −1.28 (0.011) | 115,589 | 51,620 |
| DPtD1 | −7.06∗∗ (0.009) | 127,232 | 56,885 | −5.4∗∗ (0.015) | 107,661 | 47,440 | −2.83+ (0.016) | 107,661 | 47,440 |
| DPT2 | −7.9∗∗ (0.011) | 123,278 | 54,942 | −4.59∗∗ (0.015) | 105,649 | 46,504 | −2.3 (0.015) | 105,649 | 46,504 |
| DPT3 | −9.27∗∗ (0.012) | 120,074 | 53,317 | −3.38∗ (0.015) | 104,550 | 45,883 | −2.43+ (0.014) | 104,550 | 45,883 |
| Polio1 | −6.98∗∗ (0.009) | 127,618 | 57,063 | −4.94∗∗ (0.014) | 108,685 | 47,976 | −2.97∗ (0.015) | 108,685 | 47,976 |
| Polio2 | −8.21∗∗ (0.011) | 123,368 | 55,011 | −5.19∗∗ (0.014) | 108,904 | 48,014 | −3.79∗ (0.015) | 108,904 | 48,014 |
| Polio3 | −10.28∗∗ (0.012) | 120,282 | 53,433 | −3.91∗∗ (0.014) | 110,970 | 48,982 | −3.05∗ (0.013) | 110,970 | 48,982 |
| Measles | 1.68 (0.017) | 99,223 | 43,513 | 1.85 (0.023) | 82,161 | 35,443 | 2.26 (0.022) | 82,161 | 35,443 |
Note: ∗Coefficient of COVID-affected indicator. BCG, Bacillus Calmette–Guérin; HepB0, hepatitis B given at birth; DPT, diphtheria, pertussis, tetanus; standard errors in parentheses. +p < 0.1, ∗p < 0.05, ∗∗p < 0.01.